![Mark Cochran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Cochran
Président chez
IFABRIC CORP.
Fortune : 145 795 $ au 30/09/2026
Profil
Dr. Mark A. Cochran is a Chairman at iFabric Corp., an Independent Director at Microbix Biosystems, Inc., a Chief Operating Officer & Director at Neuro-Innovators LLC and a Managing Director at Johns Hopkins Healthcare Solutions.
He is on the Board of Directors at Microbix Biosystems, Inc. and Neuro-Innovators LLC.
Dr. Cochran was previously employed as an Executive Director by Johns Hopkins Medicine, Inc., a Founding Partner by NeuroVentures Capital LLC, a Co-Founder by Protein Sciences Corp., a Vice President-Business Development by Bayer Pharmaceuticals Corp., a Chief Executive Officer by Blanchette Rockefeller Neurosciences Institute, an Executive Director by Johns Hopkins Health Plans LLC, a Senior Member by Lumira Capital Investment Management, Inc., and a Chairman & Interim Chief Executive Officer by Rivanna Pharmaceuticals, Inc. He also served on the board at Acumen Pharmaceuticals, Inc. and Transgeneron Therapeutics, Inc. He received his undergraduate degree from the University of Toronto, a graduate degree from the University of Guelph and a doctorate degree from Queen's University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/02/2026 | 549 277 ( 0,4 % ) | 118 095 $ | 30/09/2026 | |
IFABRIC CORP. 0,03 % | 16/05/2025 | 10 000 ( 0,03 % ) | 27 700 $ | 30/09/2026 |
Postes actifs de Mark Cochran
| Sociétés | Poste | Début |
|---|---|---|
| MICROBIX BIOSYSTEMS INC. | Directeur/Membre du Conseil | 16/10/2002 |
| IFABRIC CORP. | Président | 01/04/2020 |
Neuro-Innovators LLC
 Neuro-Innovators LLC BiotechnologyHealth Technology Operates as a clinical-stage drug company that develops neurorestorative medicine | Directeur des opérations | - |
Anciens postes connus de Mark Cochran
| Sociétés | Poste | Fin |
|---|---|---|
NeuroVentures Capital LLC
 NeuroVentures Capital LLC Investment ManagersFinance NeuroVentures Capital invests in companies located in the United States and Canada. The firm targets companies focused on discovery, development, and marketing of new drugs, therapeutics, medical devices, and central nervous system biotechnology. It provides financing for early and later stage capital requirements. | Fondateur | 31/12/2020 |
Johns Hopkins Medicine, Inc.
 Johns Hopkins Medicine, Inc. Hospital/Nursing ManagementHealth Services Operates a hostpital | Directeur/Membre du Conseil | 01/08/2020 |
Blanchette Rockefeller Neurosciences Institute
 Blanchette Rockefeller Neurosciences Institute BiotechnologyHealth Technology Engages in the research and development of drugs | President | 14/06/2010 |
Transgeneron Therapeutics, Inc.
 Transgeneron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic medicine that promotes tissue regeneration | Directeur/Membre du Conseil | - |
Rivanna Pharmaceuticals, Inc.
 Rivanna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Directeur Général | - |
Formation de Mark Cochran
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
47
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Protein Sciences Corp.
 Protein Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
Microbix Biosystems, Inc.
 Microbix Biosystems, Inc. BiotechnologyHealth Technology Develops biological products and technologies | Health Technology |
Acumen Pharmaceuticals, Inc.
 Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
Rivanna Pharmaceuticals, Inc.
Rivanna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Bayer Pharmaceuticals Corp. | |
Transgeneron Therapeutics, Inc.
Transgeneron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic medicine that promotes tissue regeneration | Health Technology |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeuroVentures Capital LLC
NeuroVentures Capital LLC Investment ManagersFinance NeuroVentures Capital invests in companies located in the United States and Canada. The firm targets companies focused on discovery, development, and marketing of new drugs, therapeutics, medical devices, and central nervous system biotechnology. It provides financing for early and later stage capital requirements. | Finance |
University of Guelph
 University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johns Hopkins Medicine, Inc.
Johns Hopkins Medicine, Inc. Hospital/Nursing ManagementHealth Services Operates a hostpital | Health Services |
Blanchette Rockefeller Neurosciences Institute
Blanchette Rockefeller Neurosciences Institute BiotechnologyHealth Technology Engages in the research and development of drugs | Health Technology |
Johns Hopkins Health Plans LLC
 Johns Hopkins Health Plans LLC Packaged SoftwareTechnology Services Provides health analytics software services | Technology Services |
iFabric Corp.
 iFabric Corp. Apparel/FootwearConsumer Non-Durables Manufactures and distributes ladies intimate apparel and accessories | Consumer Non-Durables |
Neuro-Innovators LLC
Neuro-Innovators LLC BiotechnologyHealth Technology Operates as a clinical-stage drug company that develops neurorestorative medicine | Health Technology |
